Protalix Biotherapeutics Inc
0 sources
Financials
0001104659-26-029858Summary
Protalix Biotherapeutics Inc is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (55 views/month).[2]
Key Facts
- Country: Israel[3], US[4]
- Instance of: public company[5]
- Founder: Joseph Chaaltiel[6]
- Headquarters location: Karmiel[7]
- Stock exchange: NYSE American[8], Tel Aviv Stock Exchange[9]
- Industry: biotechnology[10]
- Inception: 1993[11]
- Location of formation: United States[12]
- Official website: http://www.protalix.com/[13], https://www.protalix.com[14]
- Email address: mailto:eyal.rubin@protalix.com[15]
- Product or material produced: taliglucerase alfa[16]
- Phone number: +972-4-9889488[17]
- Official name: פרוטליקס ביות'רפיוטיקס אינק[18]
- Legal form: limited company[19], XTIQ[20]
- Market capitalization: 178,814,000 new shekel[21]
- Fax number: +972-4-9889489[22]
- Street address: סנונית 2, כרמיאל[23]
Why It Matters
Protalix Biotherapeutics Inc is known by 5 alternative names across languages and contexts.[24]